A Population-Level Assessment of Smoking Cessation Following a Diagnosis of Tobacco- or Nontobacco-Related Cancer Among United States Adults

Overview

Journal J Smok Cessat

Date 2021 Jul 26

PMID 34306234

Citations 2

Authors

Richard S Matulewicz

Marc A Bjurlin

Zachary Feuer

Danil V Makarov

Scott E Sherman

Joy Scheidell

Maria R Khan

Omar El-Shahawy

Affiliations

Soon will be listed here.

Abstract

Introduction: Smoking cessation after a cancer diagnosis can significantly improve treatment outcomes and reduce the risk of cancer recurrence and all-cause mortality.

Aim: We sought to measure the association between cancer diagnosis and subsequent smoking cessation.

Methods: Data was sourced from the Population Assessment of Health and Tobacco (PATH) study, a representative population-based sample of United States adults. Our analytic sample included all adult smokers at Wave I, our baseline. The exposure of interest was either a tobacco-related cancer diagnosis, nontobacco-related cancer diagnosis, or no cancer diagnosis (the referent) reported at Wave II or III. The primary outcome was smoking cessation after diagnosis, at Wave IV. . Our sample was composed of 7,286 adult smokers at the baseline representing an estimated 40.9 million persons. Smoking cessation rates after a diagnosis differed after a tobacco-related cancer (25.9%), a nontobacco-related cancer (8.9%), and no cancer diagnosis (17.9%). After adjustment, diagnosis with a tobacco-related cancer was associated with a higher odds of smoking cessation (OR 1.83, 95% CI 1.00-3.33) compared to no cancer diagnosis. Diagnosis with a nontobacco-related cancer was not significantly linked to smoking cessation (OR 0.52, 95% CI 0.48-1.45).

Conclusion: Diagnosis with a tobacco-related cancer is associated with greater odds of subsequent smoking cessation compared to no cancer diagnosis, suggesting that significant behavioral change may occur in this setting.

Citing Articles

Motivating smoking cessation among patients with cancers not perceived as smoking-related: a targeted intervention.

Martinez U, Brandon T, Warren G, Simmons V Cancer Causes Control. 2024; 36(2):127-134.

PMID: 39448437 PMC: 11774673. DOI: 10.1007/s10552-024-01931-y.

Supporting Smokers in Difficult Settings: Suggestions for Better Education and Counseling in Cancer Centers in Jordan.

Hawari F, Abu Alhalawa M, Alshraiedeh R, Al Nawaiseh A, Khamis A, Dodin Y Curr Oncol. 2022; 29(12):9335-9348.

PMID: 36547146 PMC: 9776699. DOI: 10.3390/curroncol29120732.

References

Cahill K, Stevens S, Perera R, Lancaster T . Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; (5):CD009329. PMC: 8406789. DOI: 10.1002/14651858.CD009329.pub2. View

Newsom J, Huguet N, McCarthy M, Ramage-Morin P, Kaplan M, Bernier J . Health behavior change following chronic illness in middle and later life. J Gerontol B Psychol Sci Soc Sci. 2011; 67(3):279-88. PMC: 3325087. DOI: 10.1093/geronb/gbr103. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Gritz E, Fingeret M, Vidrine D, Lazev A, Mehta N, Reece G . Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2005; 106(1):17-27. DOI: 10.1002/cncr.21598. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007; 45(4):247-51. DOI: 10.1016/j.ypmed.2007.08.012. View

Nayan S, Gupta M, Strychowsky J, Sommer D . Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013; 149(2):200-11. DOI: 10.1177/0194599813490886. View

Westmaas J, Newton C, Stevens V, Flanders W, Gapstur S, Jacobs E . Does a Recent Cancer Diagnosis Predict Smoking Cessation? An Analysis From a Large Prospective US Cohort. J Clin Oncol. 2015; 33(15):1647-52. DOI: 10.1200/JCO.2014.58.3088. View

McBride C, Ostroff J . Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Control. 2003; 10(4):325-33. DOI: 10.1177/107327480301000407. View

Tseng T, Lin H, Martin M, Chen T, Partridge E . Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Surviv. 2010; 4(4):313-21. DOI: 10.1007/s11764-010-0127-9. View

10.

Keenan P . Smoking and weight change after new health diagnoses in older adults. Arch Intern Med. 2009; 169(3):237-42. PMC: 3752594. DOI: 10.1001/archinternmed.2008.557. View

11.

Zevallos J, Mallen M, Lam C, Karam-Hage M, Blalock J, Wetter D . Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; 115(19):4636-44. PMC: 9278696. DOI: 10.1002/cncr.24499. View

12.

Chen R, Pierce J, Leas E, White M, Kealey S, Strong D . Use of Electronic Cigarettes to Aid Long-Term Smoking Cessation in the United States: Prospective Evidence From the PATH Cohort Study. Am J Epidemiol. 2020; 189(12):1529-1537. PMC: 7705599. DOI: 10.1093/aje/kwaa161. View

13.

Sosnowski R, Kamecki H, Bjurlin M, Przewozniak K . The diagnosis of bladder cancer: are we missing a teachable moment for smoking cessation?. Transl Androl Urol. 2019; 8(Suppl 3):S318-S321. PMC: 6642978. DOI: 10.21037/tau.2019.05.15. View

14.

Taylor K, Cox L, Zincke N, Mehta L, McGuire C, Gelmann E . Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007; 56(1):125-34. DOI: 10.1016/j.lungcan.2006.11.015. View

15.

Winters B, Wen L, Holt S, Dash A, Gore J, Schade G . Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes Survey. J Urol. 2019; 202(2):241-246. DOI: 10.1097/JU.0000000000000206. View

16.

Garces Y, Schroeder D, Nirelli L, Croghan G, Croghan I, Foote R . Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007; 30(5):531-9. DOI: 10.1097/COC.0b013e318059adfc. View

17.

Zheng Y, Cao X, Wen J, Yang H, Luo K, Liu Q . Smoking affects treatment outcome in patients with resected esophageal squamous cell carcinoma who received chemotherapy. PLoS One. 2015; 10(4):e0123246. PMC: 4395356. DOI: 10.1371/journal.pone.0123246. View

18.

Hartmann-Boyce J, Chepkin S, Ye W, Bullen C, Lancaster T . Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018; 5:CD000146. PMC: 6353172. DOI: 10.1002/14651858.CD000146.pub5. View

19.

Toll B, Brandon T, Gritz E, Warren G, Herbst R . Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013; 19(8):1941-8. PMC: 5992896. DOI: 10.1158/1078-0432.CCR-13-0666. View

20.

Mayer D, Carlson J . Smoking patterns in cancer survivors. Nicotine Tob Res. 2010; 13(1):34-40. PMC: 3001958. DOI: 10.1093/ntr/ntq199. View